169 related articles for article (PubMed ID: 17851376)
1. Treating cancer-related breakthrough pain: the oral transmucosal route.
Laverty D
Int J Palliat Nurs; 2007 Jul; 13(7):326-31. PubMed ID: 17851376
[TBL] [Abstract][Full Text] [Related]
2. Actiq: an effective oral treatment for cancer-related breakthrough pain.
Laverty D
Br J Community Nurs; 2007 Jul; 12(7):311, 313-6. PubMed ID: 17851311
[TBL] [Abstract][Full Text] [Related]
3. Fentanyl buccal tablet.
Messina J; Darwish M; Fine PG
Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
[TBL] [Abstract][Full Text] [Related]
4. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial.
Mercadante S; Radbruch L; Davies A; Poulain P; Sitte T; Perkins P; Colberg T; Camba MA
Curr Med Res Opin; 2009 Nov; 25(11):2805-15. PubMed ID: 19792837
[TBL] [Abstract][Full Text] [Related]
5. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
6. A review of the pharmacokinetic profile of transmucosal fentanyl formulations.
Moore N; Darwish M; Amores X; Schneid H
Curr Med Res Opin; 2012 Nov; 28(11):1781-90. PubMed ID: 23020252
[TBL] [Abstract][Full Text] [Related]
7. [A New Therapeutic Approach for Cancer-Related Breakthrough Pain - Focused on Oral Transmucosal Fentanyl].
Yomiya K; Kaneshima M; Kyosaka B; Warita E; Hosonuma R; Osato S
Gan To Kagaku Ryoho; 2017 Apr; 44(4):289-293. PubMed ID: 28428506
[TBL] [Abstract][Full Text] [Related]
8. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.
Mystakidou K; Katsouda E; Parpa E; Tsiatas ML; Vlahos L
J Opioid Manag; 2005; 1(1):36-40. PubMed ID: 17315410
[TBL] [Abstract][Full Text] [Related]
9. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.
Mystakidou K; Katsouda E; Parpa E; Tsiatas ML; Vlahos L
Am J Hosp Palliat Care; 2005; 22(3):228-32. PubMed ID: 15909786
[TBL] [Abstract][Full Text] [Related]
10. Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology.
Mystakidou K; Tsilika E; Tsiatas M; Vlahos L
Int J Nanomedicine; 2007; 2(1):49-54. PubMed ID: 17722512
[TBL] [Abstract][Full Text] [Related]
11. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.
Portenoy RK; Taylor D; Messina J; Tremmel L
Clin J Pain; 2006; 22(9):805-11. PubMed ID: 17057563
[TBL] [Abstract][Full Text] [Related]
12. [Oral transmucosal fentanyl citrate (OTFC) in the treatment of breakthrough pain].
Borgbjerg FM; Rosenberg J
Ugeskr Laeger; 2000 Sep; 162(39):5237-40. PubMed ID: 11043058
[TBL] [Abstract][Full Text] [Related]
13. Oral transmucosal fentanyl citrate: overview of pharmacological and clinical characteristics.
Mystakidou K; Katsouda E; Parpa E; Vlahos L; Tsiatas ML
Drug Deliv; 2006; 13(4):269-76. PubMed ID: 16766468
[TBL] [Abstract][Full Text] [Related]
14. Alternatives to oral opioids for cancer pain.
Mercadante S; Fulfaro F
Oncology (Williston Park); 1999 Feb; 13(2):215-20, 225; discussion 226-9. PubMed ID: 10079471
[TBL] [Abstract][Full Text] [Related]
15. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients.
Farrar JT; Cleary J; Rauck R; Busch M; Nordbrock E
J Natl Cancer Inst; 1998 Apr; 90(8):611-6. PubMed ID: 9554444
[TBL] [Abstract][Full Text] [Related]
16. Newer generation fentanyl transmucosal products for breakthrough pain in opioid-tolerant cancer patients.
Elsner F; Zeppetella G; Porta-Sales J; Tagarro I
Clin Drug Investig; 2011; 31(9):605-18. PubMed ID: 21819159
[TBL] [Abstract][Full Text] [Related]
17. Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ).
Taylor DR; Webster LR; Chun SY; Reinking J; Stegman M; Shoemaker S; Fortner B
Pain Med; 2007 Apr; 8(3):281-8. PubMed ID: 17371416
[TBL] [Abstract][Full Text] [Related]
18. [Breakthrough pain--analysis and therapy. A pilot study of a new drug, transmucosal fentanyl (Actiq)].
Johansson H; Arnér S
Lakartidningen; 2004 Feb; 101(7):552-4. PubMed ID: 15024861
[No Abstract] [Full Text] [Related]
19. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study.
Portenoy RK; Messina J; Xie F; Peppin J
Curr Med Res Opin; 2007 Jan; 23(1):223-33. PubMed ID: 17207304
[TBL] [Abstract][Full Text] [Related]
20. Oral transmucosal fentanyl: new preparation. For breakthrough cancer pain when morphine fails.
Prescrire Int; 2002 Aug; 11(60):106-7. PubMed ID: 12199262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
